Screen and identification of the protein-protein interactors of NOR1, A novel gene down-regulated in nasopharyngeal carcinoma

Progress in Biochemistry and Biophysics

Volumn 36, Issue 6, 2009, Pages 709-714

  Xiang, Bo ^a   Wang, Li ^a   Yi, Mei ^b   Ouyang, Jue ^a   Li, Xia Yu ^a   Zhang, Zu Ping ^a   Li, Xiao Ling ^a   Li, Gui Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Nor1 protein; OSCP; Protein protein interaction; Yeast two hybrid system

Indexed keywords

EID: 70349207206     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2008.00684     Document Type: Article

References (18)

1. Nie X, Zhang B, Li X, et al. Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line. J Cancer Res Clin Oncol, 2003, 129(7): 410-414 (Pubitemid 37006396)
2. Li G Y, Liu H Y, Zhou M, et al. Prog Biochem Biophys, 2006, 33 (10): 922-931
3. Xiong W, Zeng Z Y, Xiao B Y, et al. Prog Biochem Biophys, 2003, 30(3): 401-405
4. Nie X M,Gui R, Li D Q, eT aL. Prog Biochem Biophys, 2005, 32(8): 777-780
5. Fields S, Song O. A novel genetic system to detect protein-protein interactions. Nature, 1989, 340(6230): 245-246 (Pubitemid 19171591)
6. Yang J, Liu X S, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 1997, 275(5303): 1129-1132 (Pubitemid 27097312)
7. Schägger H. Blue-native gels to isolate protein complexes from mitochondria. Meth Cell Biol, 2001, 65:231-244 (Pubitemid 33798123)
8. Cuezva J M, Krajewska M, de Heredia M L, et al. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res, 2002, 62(22): 6674-6681 (Pubitemid 35364137)
9. Isidoro A, Martinez M, Fernandez P L, et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J, 2004, 378(Pt1): 17-20 (Pubitemid 38299539)
10. Cuezva J M, Chen G, Alonso A M, et al. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis, 2004, 25(7):1157-1163 (Pubitemid 38968043)
11. Capuano F, Varone D, D'Eri N, et al. Oxidative phosphorylation and F0F1 ATP synthase activity of human hepatocellular carcinoma. Biochem MoI Biol Int, 1996, 38(5): 1013-1022 (Pubitemid 26334703)
12. Shin Y K, Yoo B C, Chang H J, et al. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res, 2005, 65(8): 3162-3170 (Pubitemid 40524597)
13. Zheng J, Ramirez V D. Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase. J Steroid Biochem Mole Biol, 1999, 68(1-2): 65-75 (Pubitemid 29130387)
14. Zheng J, Ramirez V D. Rapid inhibition of rat brain mitochondrial proton F0F1-ATPase activity by estrogens: comparison with Naq, Kq-ATPase of porcine cortex. Europ J Pharm, 1999, 368(1): 95-102 (Pubitemid 29106419)
15. o-ATPaSe as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chem Biol, 2005, 12(4): 485-496
16. Prescott M, Bush N C, Nagley P, et al. Properties of yeast cells depleted of the OSCP subunit of mitochondrial ATP synthase by regulated expression of the ATP5 gene. Biochem Mol Biol Int, 1994, 34(4): 789-799 (Pubitemid 24347422)
17. Annaert W G, Esselens C, Baert V, et al. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron, 2001, 32(4): 579-589 (Pubitemid 33145193)
18. Gietz R D, Triggs-Raine B, Robbins A, et al. Identification of proteins that interact with a protein of interest: applications of the yeast two-hybrid system. Mol Cell Biochem, 1997, 172(1-2): 67-79 (Pubitemid 27374575)